Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3095509rdf:typepubmed:Citationlld:pubmed
pubmed-article:3095509lifeskim:mentionsumls-concept:C0178693lld:lifeskim
pubmed-article:3095509lifeskim:mentionsumls-concept:C0025663lld:lifeskim
pubmed-article:3095509lifeskim:mentionsumls-concept:C0005821lld:lifeskim
pubmed-article:3095509lifeskim:mentionsumls-concept:C0000665lld:lifeskim
pubmed-article:3095509lifeskim:mentionsumls-concept:C0041196lld:lifeskim
pubmed-article:3095509lifeskim:mentionsumls-concept:C0205307lld:lifeskim
pubmed-article:3095509lifeskim:mentionsumls-concept:C0303403lld:lifeskim
pubmed-article:3095509lifeskim:mentionsumls-concept:C0022702lld:lifeskim
pubmed-article:3095509pubmed:issue11lld:pubmed
pubmed-article:3095509pubmed:dateCreated1986-12-8lld:pubmed
pubmed-article:3095509pubmed:abstractTextThe effect of labeling media on the kinetics of[111In]platelets was evaluated by performing a paired crossover study in eight normal human subjects using tropolone and oxine methods. Platelets were labeled in autologous plasma with [111In]tropolone (In-tr) and in ACD-saline with [111In]oxine (In-ox) and reinjected. Starting at 1 hr, ten blood samples were obtained over an 8-day period. The in vivo platelet recovery was higher at 1 hr and throughout the 8 days of study with In-tr and the gamma camera images showed less uptake in liver and spleen than with In-ox. When platelet life-span (PLS) was estimated using all ten samples, only linear regression showed that the platelet life-span was longer with In-tr (10.7 +/- 1.5) than with In-ox (9.5 +/- 0.8). When the PLS was estimated excluding the 1-hr sample point, the life-span of platelets was significantly longer with In-tr than with In-ox based on three out of four models of curve fitting. These results demonstrate that platelets labeled with In-tr in plasma are preserved better in circulation and have equal or longer life-span than platelets labeled with In-ox in ACD-saline.lld:pubmed
pubmed-article:3095509pubmed:languageenglld:pubmed
pubmed-article:3095509pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3095509pubmed:citationSubsetIMlld:pubmed
pubmed-article:3095509pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3095509pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3095509pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3095509pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3095509pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3095509pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3095509pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3095509pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3095509pubmed:statusMEDLINElld:pubmed
pubmed-article:3095509pubmed:monthNovlld:pubmed
pubmed-article:3095509pubmed:issn0161-5505lld:pubmed
pubmed-article:3095509pubmed:authorpubmed-author:FusterVVlld:pubmed
pubmed-article:3095509pubmed:authorpubmed-author:GoldsmithS...lld:pubmed
pubmed-article:3095509pubmed:authorpubmed-author:BadimonLLlld:pubmed
pubmed-article:3095509pubmed:authorpubmed-author:Vallabhajosul...lld:pubmed
pubmed-article:3095509pubmed:authorpubmed-author:RanaMMlld:pubmed
pubmed-article:3095509pubmed:authorpubmed-author:MachacJJlld:pubmed
pubmed-article:3095509pubmed:authorpubmed-author:LipszycHHlld:pubmed
pubmed-article:3095509pubmed:issnTypePrintlld:pubmed
pubmed-article:3095509pubmed:volume27lld:pubmed
pubmed-article:3095509pubmed:ownerNLMlld:pubmed
pubmed-article:3095509pubmed:authorsCompleteYlld:pubmed
pubmed-article:3095509pubmed:pagination1669-74lld:pubmed
pubmed-article:3095509pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3095509pubmed:meshHeadingpubmed-meshheading:3095509-...lld:pubmed
pubmed-article:3095509pubmed:meshHeadingpubmed-meshheading:3095509-...lld:pubmed
pubmed-article:3095509pubmed:meshHeadingpubmed-meshheading:3095509-...lld:pubmed
pubmed-article:3095509pubmed:meshHeadingpubmed-meshheading:3095509-...lld:pubmed
pubmed-article:3095509pubmed:meshHeadingpubmed-meshheading:3095509-...lld:pubmed
pubmed-article:3095509pubmed:meshHeadingpubmed-meshheading:3095509-...lld:pubmed
pubmed-article:3095509pubmed:meshHeadingpubmed-meshheading:3095509-...lld:pubmed
pubmed-article:3095509pubmed:meshHeadingpubmed-meshheading:3095509-...lld:pubmed
pubmed-article:3095509pubmed:meshHeadingpubmed-meshheading:3095509-...lld:pubmed
pubmed-article:3095509pubmed:meshHeadingpubmed-meshheading:3095509-...lld:pubmed
pubmed-article:3095509pubmed:meshHeadingpubmed-meshheading:3095509-...lld:pubmed
pubmed-article:3095509pubmed:meshHeadingpubmed-meshheading:3095509-...lld:pubmed
pubmed-article:3095509pubmed:meshHeadingpubmed-meshheading:3095509-...lld:pubmed
pubmed-article:3095509pubmed:meshHeadingpubmed-meshheading:3095509-...lld:pubmed
pubmed-article:3095509pubmed:year1986lld:pubmed
pubmed-article:3095509pubmed:articleTitleIndium-111 platelet kinetics in normal human subjects: tropolone versus oxine methods.lld:pubmed
pubmed-article:3095509pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3095509pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3095509lld:pubmed